Ultrastructural changes and immunohistochemical localization of nitric oxide synthase, advanced glycation end products and NF-kappa B in aorta of streptozotocin treated Mongolian gerbils.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Nihon Ika Daigaku zasshi

• Publication date

  1999-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1272/JNMS.66.166PMID 10401233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AGE and Endothelial Cells

  1998cited by this paper
• Effects of serum of streptozotocin-induced diabetic rats on vascular smooth muscle cell growth in vitro.

  1998cited by this paper
• Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat.

  1998cited by this paper
• Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments.

  1997cited by this paper
• Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE.

  1997cited by this paper
• Blood coagulability and fibrinolysis in streptozotocin-induced diabetic rats.

  1997cited by this paper
• High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha.

  1997cited by this paper
• Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.

  1997cited by this paper
• Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.

  1997cited by this paper
• Vascular Biology of Diabetic Macroangiopathy: Role of Nonenzymatic Glycation of Extracellular matrix in Atherogenesis: ―糖化反応の意義―

  1996cited by this paper
• Human inducible nitric oxide synthase gene is transcriptionally regulated by nuclear factor-kappaB dependent mechanism.

  1996cited by this paper
• Cytokines, Modified Lipoproteins, and Arteriosclerosis in Diabetes

  1996cited by this paper
• Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

  1995cited by this paper
• Lilly Lecture 1993. Glycation and diabetic complications.

  1994cited by this paper
• Nitric oxide synthases in mammals.

  1994cited by this paper
• Glycation and Diabetic Complications

  1994cited by this paper
• Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

  1994cited by this paper
• Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

  1994cited by this paper
• Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury

  1994cited by this paper
• Nitric oxide generation from streptozotocin 1

  1994cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.

  1994cited by this paper
• Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus.

  1993cited by this paper
• Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation

  1993cited by this paper
• Glycation Products and the Pathogenesis of Diabetic Complications

  1992cited by this paper
• Pathogenesis of the Atherosclerotic Lesion: Implications for diabetes mellitus

  1992cited by this paper
• Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of polyol pathway

  1992cited by this paper
• Pathogenesis of the atherosclerotic lesion

  1992cited by this paper
• Hypertensive structural changes in blood vessels: do endothelial cells hold the key?

  1992cited by this paper
• Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

  1991cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper

• Experimental diabetes induced by streptozotocin in the desert gerbil, Gerbillus gerbillus, and the effects of short-term 20-hydroxyecdysone administration.

  2018cites this paper
• Experimental diabetes induced by alloxan and streptozotocin: The current state of the art.

  2016cites this paper
• Establishment and Characterization of a Newly Established Diabetic Gerbil Line

  2016cites this paper
• Oxidative Stress and Cardiovascular Disease in Diabetes

  2014cites this paper
• Histological assessment of the possible protective role of glimepiride against progression of experimentally induced diabetic nephropathy in rats

  2009influential citation
• Diabetic neuropathy and oxidative stress

  2006cites this paper
• AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.

  2005cites this paper
• Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats

  2004cites this paper
• Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients.

  2004cites this paper
• Oxidative Stress in Type 1 Diabetes

  2003cites this paper
• Gene-Targeted Mice Reveal a Critical Role for Inducible Nitric Oxide Synthase in Vascular Dysfunction During Diabetes

  2003cites this paper
• Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells.

  2002cites this paper
• Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: role of superoxide.

  2002cites this paper
• Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase

  2001cites this paper
• Localization of extracellular matrix and mitogen-activated protein kinase (MAPK) in aorta of streptozotocin treated Mongolian gerbils.

  2001cites this paper
• Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation

  2001cites this paper
• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001cites this paper
• Risk factors and pathogenesis of atherosclerotic lesion.

  1999cites this paper